Extended-Duration Thromboprophylaxis Among Acute Medically Ill Patients: An Unmet Need

Journal of Cardiovascular Pharmacology and Therapeutics
Serge KorjianC Michael Gibson

Abstract

Acute medical illnesses are associated with a prolonged elevation in inflammatory markers that predisposes patients to thrombosis beyond the duration of their hospital stay. In parallel, both observational and randomized data have demonstrated a rate of postdischarge venous thromboembolic events that often exceeds that observed in the hospital setting. Despite this significant residual risk of venous thromboembolic events following discharge among acute medically ill patients, no therapeutic strategies have been recommended to address this unmet need. Available randomized trials have demonstrated the efficacy of extending the duration of thromboprophylaxis with available anticoagulants; however, the efficacy is offset, at least in part, by an increase in bleeding events. Identification of the optimal therapeutic strategies, treatment duration, and risk assessment tools that reconcile both efficacy and safety of extended-duration thromboprophylaxis among acute medically ill patients is an area of ongoing investigation.

References

Jul 27, 2000·The New England Journal of Medicine·P J Barnes
Apr 3, 2001·Circulation·P Libby, D I Simon
Mar 6, 2002·Circulation·Peter LibbyAttilio Maseri
Mar 13, 2002·Circulation·Johann W AuerBernd Eber
Jun 9, 2004·Circulation·Marcel LeviHarry R Büller
Aug 4, 2004·Circulation·Alain LeizoroviczUNKNOWN PREVENT Medical Thromboprophylaxis Study Group
Mar 7, 2006·Thrombosis Research·Susan R KahnUNKNOWN CURVE study investigators
Apr 4, 2007·The Journal of Bone and Joint Surgery. American Volume·Chris SkedgelDavid Anderson
Jul 25, 2007·Archives of Internal Medicine·Frederick A SpencerRobert J Goldberg
Oct 23, 2009·Clinical Science·Alexander BreitensteinFelix C Tanner
Jan 9, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Juan Jesús Carrero, Peter Stenvinkel
May 27, 2010·Hospital Practice·Alpesh AminAmy Ryan
Jul 14, 2010·Journal of the American College of Cardiology·Samuel Z Goldhaber
Jul 14, 2010·Annals of Internal Medicine·Russell D HullUNKNOWN EXCLAIM (Extended Prophylaxis for Venous ThromboEmbolism in Acutely Ill Medical Patients With Prolonged Immobilization) stud
Mar 26, 2011·Chest·Alex C SpyropoulosUNKNOWN IMPROVE Investigators
Nov 15, 2011·The New England Journal of Medicine·Samuel Z GoldhaberUNKNOWN ADOPT Trial Investigators
Dec 23, 2011·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Alpesh N AminStephen Johnston
May 25, 2012·PloS One·Alvar AgustíUNKNOWN Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators
Nov 13, 2012·Thrombosis Research·Gualberto GussoniUNKNOWN FADOI Permanent Study Group on Clinical Governance
Mar 8, 2013·American Journal of Therapeutics·Onur BaserEduardo Ramacciotti
Apr 24, 2013·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Russell D HullJane Liang
Sep 21, 2013·BMJ Quality & Safety·Ashish K JhaDavid W Bates
Oct 9, 2013·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·James C IannuzziKatia Noyes
Oct 12, 2014·Arteriosclerosis, Thrombosis, and Vascular Biology·G E RaskobUNKNOWN ISTH Steering Committee for World Thrombosis Day

❮ Previous
Next ❯

Software Mentioned

EXCLAIM
MEDENOX

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.